Thu, Sep 29, 2016
Pharma major Lupin on Thursday said it has received final approval from the US health regulator to market its memantine hydrochloride extended-release capsules, which are used in the treatment of the Alzheimer's disease.
More >
Mon, Sep 26, 2016
US drugmaker Pfizer Inc, which has been considering a split into two companies for more than two years, said on Monday it would not do so because the move would not create any shareholder value.
Mon, May 30, 2016
After its failure to acquire Allergan, Pfizer recently announced plans to buy Anacor Pharmaceuticals
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
